Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 5.04M | $ -43.72M | -867.98% |
3/31/2025 | $ -3.07M | $ -46.11M | 0% |
12/31/2024 | $ 2.38M | $ -44.55M | -1868.13% |
9/30/2024 | $ -6.92M | $ -44.95M | 0% |
6/30/2024 | $ 40.68M | $ -23.94M | -58.84% |
3/31/2024 | $ 44.04M | $ -22.91M | -52.03% |
12/31/2023 | $ 44.08M | $ -21.68M | -49.2% |
9/30/2023 | $ 43.16M | $ -20.02M | -46.38% |
6/30/2023 | $ 39M | $ -21.75M | -55.75% |
3/31/2023 | $ 8.39M | $ -20.64M | -245.98% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for ERNEXA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -6.03M ] / Inv. Capital [ $ 3.88M ]
(=) ROIC [ -155.6% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.68% |
median | 3.38% |
std | 15.2% |